Recursion Pharmaceuticals Inc (RXRX)
6.91
-0.41
(-5.60%)
USD |
NASDAQ |
Nov 14, 16:00
6.82
-0.09
(-1.30%)
After-Hours: 07:36
Recursion Pharmaceuticals Cash and Short Term Investments (Quarterly): 427.65M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 427.65M |
| June 30, 2024 | 474.34M |
| March 31, 2024 | 296.33M |
| December 31, 2023 | 391.56M |
| September 30, 2023 | 387.32M |
| June 30, 2023 | 405.87M |
| March 31, 2023 | 473.14M |
| December 31, 2022 | 549.91M |
| Date | Value |
|---|---|
| September 30, 2022 | 454.65M |
| June 30, 2022 | 515.44M |
| March 31, 2022 | 591.10M |
| December 31, 2021 | 516.56M |
| September 30, 2021 | 578.91M |
| June 30, 2021 | 632.74M |
| March 31, 2021 | 214.09M |
| December 31, 2020 | 262.13M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
214.09M
Minimum
Mar 2021
632.74M
Maximum
Jun 2021
448.23M
Average
463.90M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Revance Therapeutics Inc | 184.08M |
| Eli Lilly and Co | 3.518B |
| Pfizer Inc | 9.952B |
| Twist Bioscience Corp | 289.42M |
| NovaBay Pharmaceuticals Inc | 0.776M |